down arrow

Auro Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE292C01011
  • NSEID:
  • BSEID: 530233
INR
235.00
-18 (-7.11%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 2.08 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Auro Laboratories Ltd stock-summary
stock-summary
Auro Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API). Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes. The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
Company Coordinates stock-summary
Company Details
K-56 MIDC Indl Area, Tarapur Boisar Thane Maharashtra : 401506
stock-summary
Tel: 91-22-66635456
stock-summary
auro@aurolabs.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.01%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Auro Impex Private Ltd (18.75%)

Highest Public shareholder

Shikha Lohia (1.54%)

Individual Investors Holdings

36.15%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Sharat Deorah
Chairman & Managing Director
37.5 lacs
Siddhartha Deorah
Whole-time Director
37.5 lacs
Goverdhandas Aggarwal
Independent Director
10.5 k
Kailash Chandra Bubna
Independent Director
10.5 k
Kavita Vijayakant Sharma
Independent Director
10.5 k
Kiran Kulkarni
Whole-time Director
21.0 lacs
Sweta Agarwal
Company Sec. & Compli. Officer
0
Vishal Kailash Chandra Jhunjhunwala
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Metformin HCL & CRZ
45.55
97.27%
Duty Drawback and other Export Incentives
1.26
2.69%
Traded Goods
0.02
0.04%
 
97.27
Metformin HCL & CRZ
2.73
Metformin HCL & CRZ
2.69
Duty Drawback and other Export Incentives
97.31
Duty Drawback and other Export Incentives
0.04
Traded Goods
99.96
Traded Goods
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 158 Cr (Micro Cap)

stock-summary
P/E

45.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.59

stock-summary
Return on Equity

8.29%

stock-summary
Price to Book

3.76